RBQM Resources
-
Build Vs. Buy Vs. Partner In Life Sciences: Making The Right Call
3/21/2025
Discover when life sciences organizations should develop technology in-house, buy off-the-shelf solutions, or form strategic partnerships, exploring the costs and risks that come with each approach.
-
Are You Aiming For The Bullseye Or Just The Target?
6/15/2023
Learn what this author has to say about focusing on a clinical trial's outcome when developing Risk-Based Quality Management strategies.
-
Outlook For 2025: New Forces Driving Pragmatic Innovation
12/30/2024
Clinical data trends are evolving rapidly to reduce trial complexity, improve patient experiences, and shorten development timelines.
-
Mitigating Study Risk With Performance Analytics
5/19/2022
Performance metrics for supporting risk-based management can be great, however, this author tells readers why collecting and analyzing data after a study has begun may not be the best approach.
-
Five Steps To Streamline Your Trial
7/27/2022
Explore the solution for adequately verifying and analyzing data from wearables, remote devices, and other novel data collection modalities.
-
Using Holistic Risk-Based Oversight, We Can Focus On A Trial's Most Critical Factors
7/15/2024
The industry anticipates a transformative shift towards embedding RBQM as a foundational practice in modern clinical research as a means to enhance trial efficiency and safety.
-
The Future Of Clinical Trial Oversight
4/13/2023
The future of clinical trial oversight will be shaped by the increasing use of decentralized trials, which require new approaches to data management. Discover how to leverage digital technology to enable a flexible approach to monitoring in today’s era of DCTs.
-
How Risk-Aware Are You? Establishing A Foundation For A Holistic RBQM Strategy
10/3/2022
This paper highlights why the industry is moving towards RBQM and how sponsors can build a scalable approach that protects trial participants, upholds study integrity, and increases operational efficiencies.
-
Digital Health Solution For CRS Detection And Prediction
2/27/2025
Explore how digital health technologies offer a data-driven solution to cytokine release syndrome (CRS) monitoring, reducing inpatient care requirements while ensuring patient safety.
-
RBQM For Decentralized Trials: Two Key Areas Of Focus To Reduce Your Risk
9/26/2022
This article takes a more in-depth look at Sections 5.0.5: ‘Risk Communication’ and 5.0.6: ‘Risk Review.’ in ICH-GCP E6 R2 to show how the implementation of RBQM can reduce issues and achieve holistic trial oversight in today’s complex decentralized trials.